Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase AMP-activated catalytic subunit alpha (AMPK) is a central regulator of cellular and whole-body energy homeostasis. It acts as an energy sensor, becoming activated in response to increased AMP/ATP or ADP/ATP ratios, which signal low cellular energy status. AMPK exists as a heterotrimeric complex composed of three subunits: a catalytic α subunit and regulatory β and γ subunits. The α subunit contains the kinase domain responsible for enzymatic activity. There are two genes encoding the human α-subunits: PRKAA1 (α1) and PRKAA2 (α2).
AMPK activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Kinase AMP-Activated Catalytic Subunit Alpha (AMPK).